CEB-01 by Cebiotex for Nerve Sheath Tumor: Likelihood of Approval

CEB-01 is under clinical development by Cebiotex and currently in Phase I for Nerve Sheath Tumor.

Cola cure? Study sheds light on soda’s potential for common holiday medical emergency

Researchers performed a randomized controlled trial (RCT) to evaluate the safety and effectiveness of cola in relieving esophageal meal bolus impaction.

December 14, 2023

Peanut Allergen Sensitization Seen in Younger Siblings of LEAP Study Participants

WASHINGTON — Among the younger siblings of children who consumed peanut allergens as part of the LEAP trial, there was a trend toward peanut sensitization,

March 2, 2024

Medicare wants to send $9 billion to 340B hospitals — coupled with cuts

WASHINGTON — Medicare is planning to send $9 billion in lump-sum payments to more than 1,600 hospitals that participate in a drug discount program after

July 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.